1 |
Kelley AS, Mcgarry K, Gorges R, et al. The burden of health care costs for patients with dementia in the last 5 years of life[J]. Annals of Internal Medicine, 2015, 163(10): 729-736.
|
2 |
阿尔茨海默病中医诊疗联合共识小组. 阿尔茨海默病的中医诊疗共识[J]. 中国中西医结合杂志,2018,38(5):523-529.
|
3 |
程蕊,李玺,王娟,等.载脂蛋白E基因多态性与阿尔茨海默病相关性的Meta分析[J].实用老年医学,2018,32(3):263-267.
|
4 |
Mahley R. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology[J]. Science, 1988,240(4852):622-630.
|
5 |
Yamazaki Y, Zhao N, Caulfield TR, et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies[J].Nat Rev Neurol, 2019,15(9):501-518.
|
6 |
Casey CS, Atagi Y, Yamazaki Y, et al. Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway[J]. J Biol Chem, 2015,290(22):14208-14217.
|
7 |
Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer’s disease[J]. Proc Natl Acad Sci USA,2010,107(22):10256-10261.
|
8 |
Ossenkoppele R, Cohn-Sheehy BI, La Joie R, et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer′s disease[J]. Hum Brain Mapp,2015,36(11):4421-4437.
|
9 |
Gonneaud J, Arenaza-Urquijo EM, Fouquet M, et al. Relative effect of APOEε4 on neuroimaging biomarker changes across the lifespan[J]. Neurology, 2016,87(16):1696-1703.
|
10 |
Serrano-Pozo A, Qian J, Monsell SE, et al. APOEε2 Is Associated With Milder Clinical and Pathological Alzheimer’s Disease[J]. Annals of Neurology, 2015,77(6):917-929.
|
11 |
Hashimoto T, Serrano-Pozo A, Hori Y, et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide[J]. Journal of Neuroscience, 2012,32(43):15181-15192.
|
12 |
Garai K, Verghese PB, Baban B, et al. The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation[J]. Biochemistry, 2014,53(40):6323-6331.
|
13 |
Jiang T, Chang RC, Rosenmann H,et al. Advances in Alzheimer′s disease: from bench to bedside[J].Biomed Res Int,2015:202676.
|
14 |
Ossenkoppele R, Schonhaut DR, Schöll M, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease[J]. Brain, 2016, 139(Pt 5):1551-1567.
|
15 |
Farfel JM, Yu L, De Jager PL, et al. Association of APOE with tau-tangle pathology with and without beta-amyloid[J]. Neurobiology of Aging, 2016,37:19-25.
|
16 |
Shi Y, Yamada K, Liddelow SA, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy[J]. Nature, 2017,549(7673): 523-527.
|
17 |
Niklas M, Rik O, Ruben S, et al. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study[J]. Alzheimer′s Research & Therapy, 2018, 10(1):77.
|
18 |
Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease[J]. Nature Reviews Neuroscience, 2015,16(6):358-372.
|
19 |
Nazem A, Sankowski R, Bacher M, et al. Rodent models of neuroinflammation for Alzheimer’s disease[J]. J Neuroinflammation,2015,12:74.
|
20 |
Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response[J]. Neurobiology of aging, 2009, 30(9):1350-1360.
|
21 |
Bonham LW, Desikan RS, Yokoyama JS. The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease[J]. Acta Neuropathologica Communications,2016,4(1):65.
|
22 |
侯江淇,郭蕾,张俊龙. 阿尔茨海默病中医辨治探析[J]. 辽宁中医杂志,2017,44(2):44- 46.
|
23 |
尹龙,田金洲,时晶. 阿尔茨海默病的中医病机探讨[J]. 吉林中医药,2011,31(6):495- 497.
|
24 |
张学凯,时晶,倪敬年,等. 阿尔茨海默病证候级联假说探讨[J]. 中医杂志,2019,60(9):741-744.
|
25 |
时晶,倪敬年,魏明清,等. 阿尔茨海默病证候变化与认知结局的关联性[J]. 北京中医药大学学报,2017,40(4):339-343.
|
26 |
Young AI, Benonisdottir S, Przeworski M, et al. Deconstructing the sources of genotype-phenotype associations in humans[J]. Science,2019,365(6460):1396-1400.
|
27 |
Baselmans BML, Jansen R, Ip HF, et al. Multivariate genome-wide analyses of the well-being spectrum[J]. Nat Genet, 2019,51(3):445- 451.
|
28 |
梁逸强,王佑华,周端.心脑血管相关疾病中医证候与基因多态性相关性的研究进展[J]中华中医药学刊,2011, 29(2):286-288.
|
29 |
姚雪婷,梅应兵,孙勤国,等.老年健忘中医证型分布规律及与ApoE基因相关性[J].中国老年学杂志,2020, 40(6):1281-1284.
|
30 |
武峻艳,王杰. 从中医证候谈载脂蛋白E与阿尔茨海默病的相关性[J]. 陕西中医,2019, 40(8):1109-1111.
|
31 |
李建橡,马晓聪,郑景辉,等. 痰瘀证候与载脂蛋白E基因多态性的meta分析[C]. 第九次全国中西医结合诊断学术研讨会论文集,2015, 334-339.
|
32 |
宋剑南,陈杲. 论载脂蛋白E及其基因多态性与中医痰瘀证候的关系[J]. 中国中医基础医学杂志,2002, 8(12):893- 895.
|
33 |
胡慧,王平,孔明望,等. 阿尔茨海默病模型大鼠Tau蛋白异常磷酸化表达及补肾化痰法的干预作用[J]. 时珍国医国药,2010,21(10):2681-2683.
|
34 |
苏芮,韩振蕴,范吉平,等. "毒损脑络"理论在阿尔茨海默病中医研究领域中的意义[J]. 中医杂志,2011,52(16):1370-1371.
|